Analysis of outcomes for congenital cardiac disease: can we do better?

Jeffrey P Jacobs1, Gil Wernovsky, Martin J Elliott

  • 1The Congenital Heart Institute of Florida, Division of Thoracic and Cardiovascular Surgery, All Children's Hospital, University of South Florida College of Medicine, Cardiac Surgical Associates, Saint Petersburg 33701, USA. JeffJacobs@msn.com

Cardiology in the Young
|February 23, 2008
PubMed

Insights

Establishing a common nomenclature and database is crucial for analyzing congenital heart defect treatment outcomes. This enables lifelong patient monitoring and multi-institutional research for improved care.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Services Research

Background:

  • Analysis of treatment outcomes for congenital heart disease is vital for improving patient care.
  • Current outcome analysis is limited by variations in nomenclature and data collection methods.
  • Lifelong monitoring and multi-institutional collaboration are essential for robust analysis.

Purpose of the Study:

  • To review historical developments, current practices, and future directions in nomenclature and databases for congenital heart disease outcome analysis.
  • To propose principles for establishing databases that facilitate lifelong patient monitoring and follow-up.
  • To outline necessary steps for improving outcome analysis in congenital heart disease care.

Main Methods:

  • Review of historical initiatives and collaborative projects in congenital heart surgery databases.
  • Identification of essential elements for multi-institutional databases (common nomenclature, core dataset, complexity evaluation, data verification, subspecialty collaboration, standardized follow-up).
  • Discussion of existing complexity scoring systems (RACHS-1, Aristotle) and efforts toward unification.

Main Results:

  • The International Paediatric and Congenital Cardiac Code (IPCCC) and a common minimum dataset have been developed and adopted.
  • Collaborative efforts between major surgical societies have utilized this nomenclature and database for analyzing over 100,000 patient outcomes.
  • Ongoing initiatives aim to unify complexity scoring systems and enhance data verification and subspecialty collaboration.

Conclusions:

  • A unified nomenclature and comprehensive database are fundamental for meaningful multi-institutional analysis of congenital heart disease outcomes.
  • Future efforts must focus on standardizing lifelong follow-up protocols, including non-mortality outcomes like morbidity and quality of life.
  • Continued collaboration among various medical and surgical subspecialties is critical for advancing the field.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...